Promising leukemia drug trial cut short — only 10 patients enrolled
NCT ID NCT02438761
First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 25 times
Summary
This study tested a drug called PF-05212384 in people with certain aggressive blood cancers (leukemia or related conditions) that came back or didn't respond to treatment. The goal was to see if the drug could shrink or control the cancer. Only 10 people took part before the study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA, IN RELAPSE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Toulouse
Toulouse, Midi-Pyrénées, 31059, France
-
Hôpital Cochin
Paris, Île-de-France Region, 75679, France
-
Hôpital Saint-Louis
Paris, Île-de-France Region, 75475, France
-
Institut Curie - Hôpital René Huguenin
Saint-Cloud, Île-de-France Region, 92210, France
-
Institut Paoli Calmette
Marseille, PACA, 13009, France
Conditions
Explore the condition pages connected to this study.